# FDA recall D-1155-2014

> **Mylan Institutional, Inc. (d.b.a. UDL Laboratories)** · Class III · drug recall initiated 2014-01-28.

## Product

Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20

## Reason for recall

Failed Impurity/degradation Specification

## Distribution

US: Nationwide

## Key facts

- **Recall number:** D-1155-2014
- **Recalling firm:** Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-01-28
- **Report date:** 2014-03-19
- **Termination date:** 2015-06-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Rockford, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1155-2014

## Citation

> AI Analytics. FDA recall D-1155-2014. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-1155-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*